ABSTRACT
INTRODUCTION
Manufacture of the persistent OC pesticide, CD, was banned in the United States in 1977.
Literature reviews documented CD was highly hydrophobic, generally extremely resistant to biodegradation and recalcitrant to photodegradation in the atmosphere (ATSDR 1995) . The major route of exposure for CD and OC pesticides in general was trophic transfer through the food web with maximal accumulation in top predators (Christensen et al., 2005) . OC pesticides (e.g., CD, dichlorodiphenyltrichloroethane (DDT) and dieldrin) differ from planar polychlorinated biphenyls, the chlorinated furans and dioxins in that they exhibited only slight affinity for the aryl hydrocarbon receptor (Poland and Knutson, 1982) . CD exhibited approximately equal potency in activation of the pregnane X receptor (PXR) and estrogen receptor α (ERα). Whole livers of C57BL/6 mice contained approximately 85 µM CD 16 h after administration of 5 mg CD/kg (Carpenter and Curtis, 1989) . Similar concentrations of CD in cell reporter assays indicated that CD was a weak agonist for the farnesoid X receptor (FXR) and peroxisome proliferator activated receptor alpha (PPARα). CD was a strong agonist for the human homologs of PXR and ERα. It was a weak antagonist for liver X receptor α (LXRα), a strong antagonist for LXRβ, and inhibited the binding of β-estradiol (E2) to ERβ, without agonist activity on ERβ itself. In vivo, CD pretreatment was accessed by analyzing hepatic microsomal cytochrome P450 (CYP) protein content and enzyme activities associated with these CYPs. CD induced CYP3A11 (PXR agonist) with little effect on CYP7A1 (LXR/FXR) or CYP4A1 (PPARα) (Lee el al., 2008b) . Since most OC pesticides were PXR agonists and CD was a demonstrated ERα agonist these results were not surprising (Guzelian, 1982; Coumoul et al., 2002) .
CD was unusual in that a large body of toxicological data was available for humans after a well publicized poisoning in chemical workers that occurred in the mid-1970s (Cannon et al., 1978; Guzelian, 1982) Like most OC pesticides, neurotoxicity was a prominent mode of action and tremors were a common symptom in the exposed human population (Cannon et al., 1978) . CD affected ion channels and inhibited Na + /K + ATPases in a variety of tissues (Narahashi et al., 1998; Desaiah, 1982) . It was also a liver carcinogen in both rats and mice (Reuber, 1978) . CD altered lipid homeostasis in a variety of species.
Ishikawa showed single doses of CD and dieldrin decreased total plasma CH and triglycerides in rats (Ishikawa et al., 1978 (Carpenter and Curtis, 1991; Lee et al., 2008a) . Additionally, these single doses of CD altered lipoprotein metabolism in fasted mice (Lee et al., 2008b) . High density lipoprotein (HDL) CH was not affected by CD pretreatment, but the non HDL-CH decreased and the HDL-CH:total plasma CH ratio increased in fasted mice (Lee et al., 2008b) .The same authors showed CD pretreatment increased the biliary excretion of exogenous 14 [C]CH 4 h after administration without effect on hepatic ABCG8 or SR-BI proteins by immunoquantitation (Lee et al., 2008a) .
SR-BI mediated selective lipid uptake (SLU) from HDL and reducing its expression increased plasma HDL-CH and decreased biliary CH in rodents (Rhainds and Brissette, 2004; Rigotti et al., 2003) . SR-BII was an alternative splice variant of the SR-BI gene that also mediated SLU from HDL but is expressed at much lower levels in liver (Webb et al., 1998) . The role it played in lipid homeostasis was not clear.
One possible explanation for the altered lipid homeostasis after CD exposure was alterations in cytosolic CH binding proteins. The intracellular transport of CH is complex and both vesicular and non-vesicular transport mechanisms are involved (Ikonen, 2008; Prinz, 2007 (Ikonen, 2008; Prinz, 2007) . A proteomic approach was utilized in our laboratory because of the great potential of that technique for quickly identifying and characterizing relative changes in multiple hepatic cytosolic proteins.
MATERIALS AND METHODS

Chemicals
CD was purchased from Chem Service (West Chester, PA). Purity (99%) was confirmed by gas chromatography-electron ionization/mass spectrometry. Bicinchoninic acid (BCA) protein assay reagents were purchased from Pierce Biotechnology Inc. (Rockford, IL).
iTRAQ reagents were purchased from Applied Biosystems (ABI, Foster City, CA).
Burdick and Jackson solvents (VWR, West Chester, PA) were used for all high performance liquid chromatography (HPLC). All other chemicals were from Sigma (St.
Louis, MO).
Treatment of mice
Six-seven week old male C57BL/6 mice were purchased from Simenson Laboratory (Gilroy, CA). They were randomly assigned to one of three groups: control, low dose (5 mg CD/kg) CD, or high dose (15 mg CD/kg). 
Tissue Preparation
Liver was homogenized with a Polytron PT 3000 (Brinkmann Instruments, Westbury CT) 
PAGE and Western Blot Analysis
Cytosol, debris and microsome fractions were prepared as described above. Proteins ( Protein (100 µg) samples were precipitated with six volumes of ice cold acetone and labeled with iTRAQ reagents as detailed below.
Tissue Preparation for iTRAQ Experiments
iTRAQ Labeling
Samples were labeled with iTRAQ reagents according to the manufacturers' protocol.
Control samples were labeled with iTRAQ 114.1 or 116.1 m/z, while CD treated samples (15 mg/kg) were labeled with iTRAQ 115.1 or 117.1 m/z. An iTRAQ sample consisted of 100 µg of protein from a control animal pooled with 100 µg of protein from a CD treated animal. One animal pair was used for each iTRAQ sample, and four pairs were analyzed.
Two technical replicates were run on two instruments (details below) for each sample pair. The iTRAQ ratios from the replicates were then averaged. Mean iTRAQ protein ratios were generated using the average ratio from both instruments. Ratios were then averaged across the biological sample pairs. A complete description this protocol was reported elsewhere (Scheri et al., 2008) .
Mass Spectrometry
After nano high pressure liquid chromatography (HPLC) (Waters nanoAcquity Ultra
Performance LC, Milford, MA), mass spectrometry (MS) was performed on a quadrapole orthogonal time-of-flight mass spectrometer (QTOF Ultima Global, Micromass/Waters, Manchester UK) and on an ABI 4700 Proteomics Analyzer (Foster City, CA). The QTOF incorporated an electro-spray ionization (ESI) source, while the 4700 used a matrix assisted laser enhanced desorption ionization (MALDI) source. Tandem mass spectra (MS/MS) were generated with each instrument.
Data was searched against the mammalian Swiss-Prot database (V55.0) using the Mascot (Matrix Science, London, UK) search engine. iTRAQ ratios were generated in Mascot and median normalized. Data sets were further analyzed with Scaffold (Proteome Software, Inc., Portland, OR). Only peptides with a probability of 80% or greater as determined by Scaffold were utilized for quantitative purposes. In the case of duplicate peptides or different charge states, the iTRAQ ratio with the highest Mascot score was used. A minimum of 2 peptides was required for protein identification.
A complete description this protocol was reported elsewhere (Scheri et al., 2008) .
Statistical Methods
Statistical analyses were conducted with either StatGraphics (StatPoint, Herndon, VA) or S-Plus (Insightful Corp, Seattle, WA). Normality of data was accessed with standardized kurtosis, standardized skewness and homogeneity of variance. Western blot data was expressed as the mean ± the standard error (SE). Following validation of normality, comparisons between two groups were performed with a Student's t-test. Multiple groups were compared with a one-way analysis of variance (ANOVA). In all cases, a 95%
confidence level was used as the criterion for significance.
Data for iTRAQ ratios was analyzed in logarithm (natural ln) space. Means were geometric. The Student's t-test was used to determine whether the mean iTRAQ ratio for a particular protein was different than 1 (0 in ln space), both within a biological sample pair and across the four biological sample pairs. In all cases, a 95% confidence level was used as the criterion for significance. was of interest to make the MS more tenable (Scheri et al., 2008) .
RESULTS
Previous
Approximately 80 proteins were detected with mass spectrometry under the conditions described in the Materials and Methods section (Scheri et al., 2008) . Four proteins exhibited mean iTRAQ protein ratios significantly different (p<0.05) than one (Table 1) while the iTRAQ protein ratio for FABP did not change.
CD pretreatment had no effect on cytosolic L-FABP protein content (normalized to β-actin) (Fig. 1) .
Although the function of SR-BII was not clear it was proposed to play a role in CH homeostasis and trafficking that was distinctly different than SR-BI (Eckhardt et al., 2004; . Therefore, the effect of CD pretreatment on SR-BII was analyzed. There was no effect of CD pretreatment on the protein levels or activity of hepatic microsomal CYP4A1, which supported that CD negligibly activated nuclear receptor PPARα (Lee el al., 2008b) . We therefore normalized the microsomal western SR-BII intensities to that of CYP4A (Fig. 2) . Hepatic microsomal SR-BII protein content increased up to 2.2-fold (p<0.05) after CD pretreatment.
SR-BII was detected on the plasma membrane and underwent rapid endocytosis (Eckhardt et al., 2004 (Scheri et al., 2008) . Approximately 80 proteins were detected in the streptomycin enriched fraction. The iTRAQ technique utilized peak ratios generated from the CD pretreated samples and controls. Ratios greater or less than one represent treatment dependent increased or decreased protein concentration respectively.
Clearly, CD pretreatment had no effect on cytosolic liver FABP (Fig. 1) and similar results were obtained for the streptomycin enriched fraction (Table 1) . Statistically significant differences from one were observed for four proteins. Although both SCP-2 and liver FABP were detected, SCP-2 did not meet the minimum criteria for protein identification. α-Enolase, PRX-1, and SBP-1 protein decreased while myosin-9 protein increased. Myosin-9 and SBP-1 played different roles in intracellular vesicular transport (van den Boom et al, 2007; Porat et al, 2000) . Since there was no effect on β-actin after CD (Fig. 1) , a generalized effect on the cytoskeleton seemed unlikely. While PRX-1 scavenged peroxides and other reactive oxygen species, the α-enolase gene encoded both a glycolytic enzyme and a transcription factor, the c-MYC binding protein (MBP-1) (Egler et al., 2005; Subramanian and Miller, 2000) . It is interesting to note that both of these proteins appeared to play important regulatory roles for the c-Myc transcription factor, a product of the c-MYC oncogene. The c-MYC oncogene was associated with a variety of cell processes, including apoptosis, cell growth, differentiation and cell cycle progression (Fernandez et al., 2003; Egler et al., 2005) . While MBP-1 bound the c-MYC promoter and down regulated c-Myc transcription, PRX-1 interacted with the c-Myc transcription factor itself (Subramanian and Miller, 2000; Egler et al., 2005) . This was perhaps related to the carcinogenicity of long-term CD exposures in rodents. However, a caveat must be added. Although the observed differences were statistically significant, the biological significance of these relatively small magnitudes, particularly using the iTRAQ technique, is questionable at best.
Multiple hepatic plasma membrane proteins mediate CH exchange between the liver and blood or bile (Ikonen, 2008; Prinz, 2007) . SR-BI transports CH from HDL into liver and the ABCG5/ABCG8 heterodimer effluxes CH into bile. Since no change in either SR-BI or ABCG8 proteins in crude hepatic membrane fractions occurred after CD pretreatment (Lee et al., 2008a) , a potential underlying mechanism for the CD stimulated biliary excretion of [ 14 C]CH was increased trafficking via a SR-BII dependent pathway. SR-BII mediated SLU from HDL but at a lower efficiency than SR-BI (Webb et al., 1998) .
However, SR-BII effluxes about twice as much free CH as SR-BI (Mulcahy et al., 2004) .
The subcellular distribution and internalization of these receptors also differs. In primary hepatocytes, SR-BI was predominantly located on the plasma membrane although a distinct pool appeared to be in late endosomes and lysosomes (Ahras et al., 2008; Eckhardt et al., 2004) . SR-BI underwent endocytosis at a much lower rate than SR-BII in CHO cells (Eckhardt et al., 2004) . SLU with SR-BI does not require endocytosis (Nieland et al., 2005; Wustner et al., 2003) . Lipids may be transported to different pools in different locations within the cell by endocytosis, and perhaps SR-BII endocytosis played a role in altering the CH content of the endocytotic compartment (Eckhardt et al., 2006) . In contrast with SR-BI, SR-BII is located primarily intracellularly and rapidly endocytosed in transferrin containing vesicles in CHO cells (Eckhardt et al., 2004) .
Hepatic microsomal SR-BII protein increased about 2.2-fold in CD-treated mice compared to controls (Fig. 2) . The total amount of SR-BII in a crude membrane fraction that included plasma membranes was not changed after CD (Fig. 3) . (Fig. 4) . Neurotoxicity was a prominent mode of action for OC pesticides and several studies reported CD inhibited Na + /K + ATPase (reviewed in Desaiah, 1982) . The increase observed in this protein was perhaps a compensatory response of this inhibited transport capacity per unit protein. 
